• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

Introduction to 3-fluoro-2-(2R)-oxiran-2-ylpyridine (CAS No: 2227649-24-1)

3-fluoro-2-(2R)-oxiran-2-ylpyridine, identified by the chemical identifier CAS No: 2227649-24-1, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the class of heterocyclic pyridines, which are widely recognized for their diverse biological activities and utility in drug development. The presence of a fluoro group and an oxiran ring in its molecular structure imparts unique chemical properties, making it a valuable intermediate in the synthesis of bioactive molecules.

The fluoro substituent, particularly at the 3-position of the pyridine ring, is a common feature in many pharmacologically active compounds. Fluorine atoms are known for their ability to modulate metabolic stability, binding affinity, and electronic properties of molecules. In the context of 3-fluoro-2-(2R)-oxiran-2-ylpyridine, the fluorine atom can enhance the lipophilicity and binding interactions with biological targets, thereby improving the overall efficacy of potential drug candidates.

The oxiran ring, also known as an epoxide, is another critical structural feature of this compound. Epoxides are versatile intermediates that can undergo various chemical transformations, including nucleophilic ring opening reactions. This property makes 3-fluoro-2-(2R)-oxiran-2-ylpyridine a valuable building block for constructing more complex molecular architectures. The stereochemistry of the oxiran ring, specifically the (2R) configuration, adds an additional layer of specificity to its reactivity and potential applications in asymmetric synthesis.

Recent advancements in medicinal chemistry have highlighted the importance of chiral auxiliaries and catalysts in the synthesis of enantiomerically pure compounds. The (2R)-configuration of the oxiran ring in 3-fluoro-2-(2R)-oxiran-2-ylpyridine aligns with this trend, as it provides a scaffold for developing enantiomerically enriched drug candidates. Such compounds are often preferred in clinical settings due to their improved selectivity and reduced side effects.

In the realm of drug discovery, 3-fluoro-2-(2R)-oxiran-2-ylpyridine has been explored as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinases. Tyrosine kinases play a crucial role in signal transduction pathways and are implicated in various diseases, including cancer. The combination of the fluoro group and the oxiran moiety offers a promising platform for designing inhibitors with enhanced potency and selectivity. For instance, recent studies have demonstrated that derivatives of this compound exhibit inhibitory activity against specific tyrosine kinases, making them attractive candidates for further development.

The role of computational chemistry and molecular modeling has been instrumental in understanding the interactions between 3-fluoro-2-(2R)-oxiran-2-ylpyridine and its biological targets. These computational approaches have enabled researchers to predict binding affinities, optimize molecular structures, and design novel analogs with improved pharmacological properties. By leveraging these tools, scientists can accelerate the discovery process and identify lead compounds more efficiently.

Moreover, green chemistry principles have influenced modern synthetic methodologies used in the preparation of 3-fluoro-2-(2R)-oxiran-2-ylpyridine. The demand for sustainable and environmentally friendly synthetic routes has led to the development of catalytic processes that minimize waste and energy consumption. For example, transition metal-catalyzed reactions have been employed to construct the oxiran ring efficiently while maintaining high enantioselectivity.

The versatility of 3-fluoro-2-(2R)-oxiran-2-ylpyridine extends beyond kinase inhibition. It has also been investigated as a precursor for developing antiviral and antibacterial agents. The unique structural features of this compound allow for modifications that can target specific viral proteases or bacterial enzymes involved in pathogenesis. Ongoing research aims to exploit these properties for creating novel therapeutic strategies against emerging infectious diseases.

In conclusion, 3-fluoro-2-(2R)-oxiran-2-ylpyridine (CAS No: 2227649-24-1) represents a significant advancement in pharmaceutical chemistry due to its structural complexity and functional diversity. Its applications in drug development span multiple therapeutic areas, including oncology, infectious diseases, and central nervous system disorders. As research continues to uncover new biological activities and synthetic methodologies, this compound is poised to play an increasingly important role in future medicinal chemistry endeavors.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)